Stručni rad

A critical assessment of thromboprophylaxis in surgically treated patients

Katarina Zdravčević-Šakić

Sažetak

Deep vein thrombosis (DVT) prophylaxis is a part of the perioperative patient care. Pulmonary emboly (PA) usually originates from thrombosis in the deep veins of the lower limbs, pelvis or inferior vena cava. Frequently these venous thrombi are asymptomatic. Venous thromboembolism is an important complication of major orthopaedic and other major surgeries. If no attempt is made to reduce the risk of thromboembolism, mortality can be up to 5% of the patients. Most of the patients who undergo surgery require mechanical or pharmacological prophylaxis. Low molecular weight heparins have considerably simplified chemical prophylaxis since a signle daily subcutaneous injection is efficient, well tolerated and cost-effective. However, several points are still a matter of debate. Does venographically proven thrombosis reflect clinical reality? Is the association of loco-regional anesthesia and anticoagulants dangerous? Should oral anticoagulants still be prescribed? How long should DVT prophylaxis be contineud post-operatively? What is the future of mechanical prophylaxis?

Ključne riječi

Surgically treated patients; Thromboprophylaxis

Hrčak ID:

191990

URI

https://hrcak.srce.hr/191990

Datum izdavanja:

1.12.1999.

Podaci na drugim jezicima: hrvatski

Posjeta: 2.220 *